K

Kyung Nam Pharm Co Ltd
KOSDAQ:053950

Watchlist Manager
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Watchlist
Price: 642 KRW -2.58% Market Closed
Market Cap: 50.2B KRW

Wall Street
Price Targets

Price Targets Summary
Kyung Nam Pharm Co Ltd

There are no price targets for Kyung Nam Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Kyung Nam Pharm Co Ltd Competitors:
Price Targets
IPCALAB
IPCA Laboratories Ltd
11% Upside
603520
Zhejiang Starry Pharmaceutical Co Ltd
53% Upside
PAHC
Phibro Animal Health Corp
16% Upside
688176
Jiangsu Yahong Meditech Co Ltd
11% Downside
4016
Middle East Pharmaceutical Industries Company SJSC
12% Upside
003850
Boryung Corp
36% Upside

Revenue
Forecast

Revenue Estimate
Kyung Nam Pharm Co Ltd

For the last 13 years the compound annual growth rate for Kyung Nam Pharm Co Ltd's revenue is 2%. The projected CAGR for the next 9 years is -4%.

2%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Kyung Nam Pharm Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Kyung Nam Pharm Co Ltd

The compound annual growth rate of Kyung Nam Pharm Co Ltd's net income for the next 9 years is 8%.

N/A
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kyung Nam Pharm Co Ltd's stock price target?
Not Available

Kyung Nam Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Kyung Nam Pharm Co Ltd's Revenue forecast?
Projected CAGR
-4%

For the last 13 years the compound annual growth rate for Kyung Nam Pharm Co Ltd's revenue is 2%. The projected CAGR for the next 9 years is -4%.

What is Kyung Nam Pharm Co Ltd's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Kyung Nam Pharm Co Ltd's net income for the next 9 years is 8%.

Back to Top